Bank Julius Baer & Co’s CureVac CVAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,000
| Closed | -$4.52K | – | 685 |
|
|
2025
Q4 | $4.52K | Sell |
1,000
-1
| -0.1% | -$5 | ﹤0.01% | 628 |
|
|
2025
Q3 | $5.39K | Sell |
1,001
-1
| -0.1% | -$5 | ﹤0.01% | 639 |
|
|
2025
Q2 | $5.44K | Buy |
1,002
+3
| +0.3% | +$12 | ﹤0.01% | 592 |
|
|
2025
Q1 | $2.77K | Buy |
999
+14
| +1% | +$49 | ﹤0.01% | 596 |
|
|
2024
Q4 | $3.71K | Buy |
+985
| New | +$2.84K | ﹤0.01% | 616 |
|
|
2024
Q1 | – | Sell |
-924
| Closed | -$3.89K | – | 537 |
|
|
2023
Q4 | $3.89K | Buy |
924
+1
| +0.1% | +$5 | ﹤0.01% | 536 |
|
|
2023
Q3 | $6K | Sell |
923
-16
| -2% | -$141 | ﹤0.01% | 514 |
|
|
2023
Q2 | $10K | Buy |
939
+10
| +1% | +$89 | ﹤0.01% | 541 |
|
|
2023
Q1 | $6K | Sell |
929
-22
| -2% | -$192 | ﹤0.01% | 576 |
|
|
2022
Q4 | $6K | Sell |
951
-122
| -11% | -$901 | ﹤0.01% | 560 |
|
|
2022
Q3 | $8K | Buy |
1,073
+109
| +11% | +$1.27K | ﹤0.01% | 550 |
|
|
2022
Q2 | $13K | Buy |
964
+56
| +6% | +$926 | ﹤0.01% | 574 |
|
|
2022
Q1 | $18K | Sell |
908
-2,273
| -71% | -$45.4K | ﹤0.01% | 560 |
|
|
2021
Q4 | $109K | Buy |
3,181
+891
| +39% | +$35.8K | ﹤0.01% | 598 |
|
|
2021
Q3 | $125K | Sell |
2,290
-445
| -16% | -$26.8K | ﹤0.01% | 611 |
|
|
2021
Q2 | $201K | Sell |
2,735
-755
| -22% | -$75.5K | ﹤0.01% | 560 |
|
|
2021
Q1 | $319K | Sell |
3,490
-112
| -3% | -$10.9K | ﹤0.01% | 504 |
|
|
2020
Q4 | $292K | Buy |
3,602
+202
| +6% | +$15.5K | ﹤0.01% | 516 |
|
|
2020
Q3 | $158K | Buy |
+3,400
| New | +$190K | ﹤0.01% | 536 |
|
Bank Julius Baer & Co's CVAC Position: Q1 2026 in Review
Bank Julius Baer & Co sold out of CureVac (CVAC) in Q1 2026, closing a stake of 1,000 shares — an estimated $4.52K sold.
Bank Julius Baer & Co first reported a position in CVAC in Q3 2020 and held it in 19 quarters. The position peaked at $319K in Q1 2021. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.
- Bank Julius Baer & Co reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
- Bank Julius Baer & Co sold 1,000 CureVac shares in Q1 2026, an estimated $4.52K.
- Bank Julius Baer & Co first reported a position in CureVac in Q3 2020 and held it in 19 quarters.
- Bank Julius Baer & Co's CureVac position peaked at $319K in Q1 2021.
- 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.
Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.